Hefei Lifeon Pharmaceutical Hits Day Low of CNY 15.98 Amid Price Pressure

Hefei Lifeon Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 9.97% and reaching an intraday low of CNY 15.98. This performance starkly contrasts with the China Shanghai Composite, which saw a modest gain of 0.85% on the same day. Over the past week, Hefei Lifeon has faced a steep decline of 22.46%, while the broader market index fell by only 3.0%. The company's year-to-date performance reflects a downturn of 25.9%, significantly underperforming the Shanghai Composite's decline of 4.35%. In terms of long-term growth, Hefei Lifeon has struggled, with net sales decreasing at an annual rate of 4.87% and operating profit declining by 2.41% over the last five years. The company has reported negative results for six consecutive quarters, indicating ongoing financial difficulties. Key financial metrics reveal a market capitalization of CNY 2,624 million, a P/E ratio of 16.00, and a dividend yield of 2.18%. The company's return on equity stands at 8.63%, while cash and equivalents have reached a low of CNY 939.75 million.